| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |